June 12th, 2024
Endoscopy support in India.
Olympus Corporation (hereinafter referred to as Olympus) has started the activities of the Offshore Development Center (ODC) in Hyderabad, Telangana, India, as part of its research and development strategy. As the first initiative, based on a strategic agreement with HCL Technologies (hereinafter referred to as HCLTech, headquartered in Noida, Uttar Pradesh, India), which provides IT services globally, Olympus will promote innovation creation and further strengthen its research and development system with the aim of providing operational income for its 10-30 billion yuan products of 401/1288/60 million yuan respectively.
Along with the establishment of ODC, we will prepare for the establishment of our own research and development center in Hyderabad in a few years. As our research and development center, it is planned to become a base following Japan, the United States, and Europe.
Hyderabad is a major city in India where the medical device industry is concentrated, and it is also known for having abundant talented researchers in the field. Olympus plans to launch a research and development base in this region in the future, aiming to further enhance the personnel and resources essential for our medical technology development, which is indispensable for the expansion of the medical business.
We are also planning a joint research project with AIG Hospitals in Hyderabad, and we expect our presence in India to be further heightened. Through cooperation with one of the leading medical institutions in India, Olympus will make the most of its expertise and knowledge cultivated in the medical business and create innovation that meets the medical needs of the world.
In 2009, we established Olympus Medical Systems India Private Limited (OMSI), a sales base for medical devices in Gurugram (Gurgaon), Haryana, and expanded our business in India with the support of many stakeholders. Through these strategic initiatives, we will further promote our global expansion and contribute to improving the standard of medical care by enhancing our ability to provide impactful medical solutions.
Comment by Andre Roggan, Executive Officer and Chief Technology Officer of Olympus
We are very pleased to report the collaboration with HCLTech, our partner in engineering and research and development services for about 10 years. Through this collaboration, we are confident that Olympus' engineering capability will be strengthened, and new innovation that will realize high-quality medical care through technology development will be born.
Comment from D. Sridhar Babu, Minister of the Department of Information Technology and Electronic Communications, as well as Industry and Commerce (I&C) of the Government of Telangana
Olympus, one of the world's major medical device manufacturers, has chosen Hyderabad as its first investment destination in India and will establish a research and development center. This is an important milestone for the medical device industry ecosystem in this city. Along with Hyderabad's strong infrastructure, strategic location, and innovative and active healthcare industry community, this investment will be a groundbreaking event for India's medical device industry. We are convinced that Olympus' advanced technology and expertise will significantly contribute to our vision of becoming a global hub for innovation and creation of medical devices. We are delighted to welcome Olympus to our ecosystem.
About HCL Technologies (HCLTech)
HCLTech, headquartered in India, is a global technology company with over 227,000 employees in more than 60 countries. It offers industry-leading services through a wide portfolio of technology solutions and products, centered around digital, engineering, cloud, and AI. It provides specialized solutions for all major industries, including financial services, manufacturing, life sciences and healthcare, technology services, communications and media, retail and consumer products, and public services. Its consolidated sales for the 12-month period up to March 2024 were $13.3 billion.
For more information, please visit: https://www.hcljapan.co.jp/ or https://www.hcltech.com/ Please visit the HCLTech Japan SNS (LinkedIn: https://www.linkedin.com/showcase/hcl-japan/) for updates.
About OlympusOlympus aims to achieve the health, safety, and fulfillment of people around the world as its purpose. As a leading medtech company, it will contribute to improving the medical standards of target diseases through the provision of optimal solutions and services that help early detection, diagnosis, and minimally invasive treatment in collaboration with healthcare professionals. For over 100 years since its founding, Olympus will continue to provide products that bring optimal value to customers globally and contribute to society. For more information, please visit the official Olympus website (www.olympus.co.jp) and X (@Olympus_Corp_JP).
www.olympus.co.jp@Olympus_Corp_JP
*The published content contains information as of the date of announcement, and the information may be changed (discontinued production and sales, changes in specifications, prices, etc.) without notice at the time of viewing.
*The published content is information released to the press, shareholders, investors, and others. It may include information on medical devices (including unapproved pharmaceuticals and medical devices), but the content is not intended for advertising or medical advice.
*We do not assume any responsibility for any damages arising from the use of the published content.
*The company and product names published in this release are trademarks or registered trademarks of their respective companies.